Revealing the diagnostic value of cerebrospinal fluid presepsin (sCD14) as a new biomarker for postneurosurgical and nosocomial central nervous system infections: A systematic review and meta-analysis of diagnostic test accuracy studies
Loading...
Date
2025-01-29
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Elsevier B.V.
Series Info
Clinical Neurology and Neurosurgery ; Volume 249 , February 2025 , Article number 108767
Scientific Journal Rankings
Abstract
Background: Central nervous system (CNS) infections represent life-threatening conditions. Emerging evidence
suggests cerebrospinal fluid (CSF) presepsin (sCD14) as a promising biomarker for these infections. However, its
diagnostic accuracy remains controversial. This study aimed to systematically evaluate the reliability of CSF
presepsin in diagnosing CNS infections through a comprehensive meta-analysis.
Methods: A systematic search of PubMed, Scopus, and Web of Science databases was conducted up to November
2024. Five prospective studies involving 384 participants were included. CSF presepsin levels were compared
between infected and non-infected patients. Pooled sensitivity, specificity, diagnostic odds ratio (DOR), positive
predictive value (PPV), and negative predictive value (NPV) were calculated using a random-effects model.
Publication bias and clinical utility were assessed through Deek’s funnel plot and Fagan’s nomogram,
respectively.
Results: Infected patients exhibited significantly higher CSF presepsin levels (mean difference: 760.16 pg/mL;
95 % confidence interval (CI): 426.26–1094.05, p < 0.01). Pooled sensitivity and specificity were 87 % (95 % CI:
82–91 %) and 67 % (95 % CI: 60–74 %), respectively, with a DOR of 13.04 (95 % CI: 7.51–22.64). The pooled
PPV and NPV were 79 % (95 % CI: 73–84 %) and 79 % (95 % CI: 71–85 %), respectively. The area under the
curve of the summary receiver operating characteristic curve was 86 %, emphasizing high diagnostic accuracy.
No statistically significant publication bias was detected (P = 0.12).
Conclusion: CSF presepsin demonstrated potential as a diagnostic biomarker for CNS infections, demonstrating
high sensitivity and moderate specificity. Further large-scale studies are needed to refine its clinical applicability
and establish standardized thresholds.
Description
Q2
Keywords
Central nervous system infections, CSF presepsin, Meningitis, Meta-analysis, sCD14, Soluble CD14, Ventriculitis
Citation
Mohammed, H. E., Nasser, M., Abouelmagd, M. E., Haseeb, M. E., Darwish, M. K., Abdelqader, M. S., Tawfik, A., Abdel-Mawla, R. E. M., & Hindawi, M. D. (2025). Revealing the diagnostic value of cerebrospinal fluid presepsin (SCD14) as a new biomarker for postneurosurgical and nosocomial central nervous system infections: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies. Clinical Neurology and Neurosurgery, 249, 108767. https://doi.org/10.1016/j.clineuro.2025.108767